![Raffaele Petrone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raffaele Petrone
Chairman at PIERREL S.P.A.
Net worth: 88 M $ as of 2024-01-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Fulvio Citaredo | M | 62 |
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland.
Università degli Studi di Napoli Federico II
| 17 years |
Alessandra Piccinino | F | 61 |
Università degli Studi di Napoli Federico II
| 11 years |
Stefano Buono | M | 57 |
Newcleo Ltd.
![]() Newcleo Ltd. Electrical ProductsProducer Manufacturing Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021. | - |
Francesco Pepe | M | 45 | 7 years | |
Mauro Fierro | M | 64 |
Università degli Studi di Napoli Federico II
| 16 years |
Rosario Bifulco | M | 69 | 17 years | |
Carmine Incoronato Petrone | M | 89 |
Fin Posillipo SpA
![]() Fin Posillipo SpA Miscellaneous Commercial ServicesCommercial Services Fin Posillipo SpA provides financial and business consulting services. It helps small and medium-sized enterprises in the health and pharmaceutical sectors such as financial advice and fiscal and administrative consulting. The company was founded in 1989 and is headquartered in Naples, Italy. | - |
Adrienne Kelbie | F | - |
Newcleo Ltd.
![]() Newcleo Ltd. Electrical ProductsProducer Manufacturing Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021. | - |
Fabio Velotti | M | 56 |
Università degli Studi di Napoli Federico II
| 5 years |
Elisabeth Rizzotti | F | - |
Newcleo Ltd.
![]() Newcleo Ltd. Electrical ProductsProducer Manufacturing Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021. | - |
Corine Raoux-Fontanet | F | - |
Newcleo Ltd.
![]() Newcleo Ltd. Electrical ProductsProducer Manufacturing Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021. | - |
Ram Selvaraju | M | 45 | 8 years | |
Florence Parly | F | 61 |
Newcleo Ltd.
![]() Newcleo Ltd. Electrical ProductsProducer Manufacturing Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021. | 1 years |
Andrea Ruben Osvaldo Levi | M | - |
Newcleo Ltd.
![]() Newcleo Ltd. Electrical ProductsProducer Manufacturing Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021. | 5 years |
Luigi Visani | M | 68 |
Pierrel Research International AG
![]() Pierrel Research International AG Pharmaceuticals: MajorHealth Technology Part of RELIEF THERAPEUTICS Holding SA, Pierrel Research International AG provides drug development and clinical research services. The company is based in Essen, Germany. The CEO of the German company is Luigi Visani. Pierrel Research International was acquired by THERAMetrics holding AG from Pierrel SpA on January 25, 2013. | - |
Maria Paola Bifulco | M | 56 | 9 years | |
Fernanda Petrone | F | 34 | 9 years | |
Pierluigi Petrone | M | - |
Petrone Group Srl
![]() Petrone Group Srl Medical DistributorsDistribution Services Part of Fin Posillipo SpA, Petrone Group Srl is a pharmaceutical wholesaler and supplier. The company is based in Naples, Italy. The Italian company was founded in 1965 by Carmine Petrone, Fernanda Petrone. The CEO is Pierluigi Petrone. | - |
Francesco Vitobello | M | - |
Fin Posillipo SpA
![]() Fin Posillipo SpA Miscellaneous Commercial ServicesCommercial Services Fin Posillipo SpA provides financial and business consulting services. It helps small and medium-sized enterprises in the health and pharmaceutical sectors such as financial advice and fiscal and administrative consulting. The company was founded in 1989 and is headquartered in Naples, Italy. | - |
Jordi Sentis | M | - |
BCN Farma SA
| - |
Carlo Zuccaro | M | - |
Newcleo Ltd.
![]() Newcleo Ltd. Electrical ProductsProducer Manufacturing Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michel Dreano | M | 67 | 3 years | |
William A. Cavendish | M | 72 |
Life Sciences Capital Srl
![]() Life Sciences Capital Srl Investment ManagersFinance Life Sciences Capital Srl(Life Sciences Capital) is a venture capital subsidiary of Fin Posillipo SpA founded in 2005 by William A. Cavendish. The firm is headquartered in Napoli, Italy. | 13 years |
Yvonne Greenstreet | M | 61 | - | |
Giorgio Chieregatti | M | 73 | - | |
Andrea Chiaravalli | M | 58 | - | |
Federico Valle | M | 46 | - | |
Roberto Berger | M | - | - | |
Marcello Massinelli | M | 53 | - | |
Muriel de Szilbereky | F | 72 | 3 years | |
Gaël Hédou | M | 52 | 3 years | |
Kapil Dhingra | M | 64 | 4 years | |
Ruggero Gramatica | M | 59 |
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | 3 years |
Tiziana Catuogno | F | 54 | - | |
Christian Merle | M | 70 | - | |
Giangiacomo Rocco di Torrepadula | M | - |
Pharmaidea SRL
![]() Pharmaidea SRL Medical DistributorsDistribution Services Pharmaidea SRL operates as a pharmaceutical company. It engages in the marketing, sales, provision of scientific information, and product distribution. The company was founded in 2000 and is headquartered in Travagliato, Italy. | 13 years |
Leopoldo Giampaolo Zambeletti | M | 55 | - | |
Steven Gannon | M | 62 | 4 years | |
Cesare Zetti | M | 57 | - | |
Maria Gabriella Colucci | F | 63 |
Università degli Studi di Napoli Federico II
| 5 years |
Michele Fiorentino | M | - |
Università degli Studi di Napoli Federico II
| 9 years |
Richard Valeix | M | 49 | 7 years | |
Danilo de Mari | M | - |
Life Sciences Capital Srl
![]() Life Sciences Capital Srl Investment ManagersFinance Life Sciences Capital Srl(Life Sciences Capital) is a venture capital subsidiary of Fin Posillipo SpA founded in 2005 by William A. Cavendish. The firm is headquartered in Napoli, Italy. | 9 years |
Filippo Celio | M | 58 |
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | - |
Roberto Tenze | M | - |
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | - |
Paolo Gualtieri | M | 63 |
Università degli Studi di Napoli Federico II
| 3 years |
Paolo Cirino Pomicino | M | 84 | - | |
Alessandro de Rosa | M | 66 |
Università degli Studi di Napoli Federico II
| 4 years |
Piergiorgio Bianchetti | M | - |
Life Sciences Capital Srl
![]() Life Sciences Capital Srl Investment ManagersFinance Life Sciences Capital Srl(Life Sciences Capital) is a venture capital subsidiary of Fin Posillipo SpA founded in 2005 by William A. Cavendish. The firm is headquartered in Napoli, Italy. | - |
Marco Ferretti | M | 62 |
Università degli Studi di Napoli Federico II
| 4 years |
Domenico Sorvillo | M | 62 |
Università degli Studi di Napoli Federico II
| 4 years |
Claude Hariton | M | 68 | - | |
Niccolò Colussi | M | - |
Life Sciences Capital Srl
![]() Life Sciences Capital Srl Investment ManagersFinance Life Sciences Capital Srl(Life Sciences Capital) is a venture capital subsidiary of Fin Posillipo SpA founded in 2005 by William A. Cavendish. The firm is headquartered in Napoli, Italy. | 6 years |
Maria Teresa Ciccone | F | 45 | - | |
Claudio Palladini | M | 50 |
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | - |
Timothy Snyder | M | 58 |
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | - |
Walter Cristelli | M | 65 |
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | - |
Ignazio Rocco di Torrepadula | M | 61 |
Università degli Studi di Napoli Federico II
| 5 years |
Andrea Benincasa | M | - |
Università degli Studi di Napoli Federico II
| 4 years |
Pasquale Vetrano | M | - |
Università degli Studi di Napoli Federico II
| 4 years |
Elena Vasco | F | 59 |
Università degli Studi di Napoli Federico II
| 4 years |
Giulio Valiante | M | 60 |
Università degli Studi di Napoli Federico II
| 4 years |
Claudio Costamagna | M | 68 | 6 years | |
Michele Russo | M | 62 |
Università degli Studi di Napoli Federico II
| 4 years |
Giancarlo Lanna | M | 65 |
Università degli Studi di Napoli Federico II
| 4 years |
Canio Giovanni Mazzaro | M | 64 |
Università degli Studi di Napoli Federico II
| 4 years |
Giuseppe Scognamiglio | M | - |
Università degli Studi di Napoli Federico II
| 3 years |
Pietro Pascale | M | 63 |
Università degli Studi di Napoli Federico II
| 4 years |
Andrea Raffone | M | 62 |
Università degli Studi di Napoli Federico II
| 4 years |
Amedeo Giurazza | M | 64 |
Università degli Studi di Napoli Federico II
| 5 years |
Riccardo Bruno | M | 64 |
Università degli Studi di Napoli Federico II
| 4 years |
Maurizio Bezzeccheri | M | 65 |
Università degli Studi di Napoli Federico II
| 6 years |
Fernando Napolitano | M | 64 |
Università degli Studi di Napoli Federico II
| 4 years |
Jordan Silverstein | M | - | 4 years | |
Annalisa Zezza | M | 66 |
Università degli Studi di Napoli Federico II
| 3 years |
Diego Pacella | M | 63 |
Università degli Studi di Napoli Federico II
| 4 years |
Ariel Davide Segre | M | 85 | - | |
Vittorio Puppo | M | - |
Life Sciences Capital Srl
![]() Life Sciences Capital Srl Investment ManagersFinance Life Sciences Capital Srl(Life Sciences Capital) is a venture capital subsidiary of Fin Posillipo SpA founded in 2005 by William A. Cavendish. The firm is headquartered in Napoli, Italy. | - |
Paolo Bassanini | M | - |
THERAMetrics holding AG
![]() THERAMetrics holding AG Pharmaceuticals: MajorHealth Technology THERAMetrics holding AG is an independent biotech company, which discovers drugs for patients suffering from rare diseases. The company was founded by Fabio Cavalli, Vera Cavalli, Patrick Pozzorini, Dorian Bevec and Michael von und zu Liechtenstein on February 9, 2001 and is headquartered in Stans, Switzerland. | - |
Rita Ciccone | M | 64 |
Università degli Studi di Napoli Federico II
| 4 years |
Maria Grazia Falchi | F | 59 | - | |
Peter Egon de Svastich | M | 80 | 4 years | |
Eugenio Aringhieri | M | - | 3 years | |
Maurizio Franco Mariani | M | 66 | - | |
Francesca Fiore | F | 57 |
Università degli Studi di Napoli Federico II
| 4 years |
Domenico Ballo | M | 61 |
Università degli Studi di Napoli Federico II
| 4 years |
Andrea D’Angelo | M | - |
Università degli Studi di Napoli Federico II
| 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
Italy | 54 | 62.07% |
France | 14 | 16.09% |
Switzerland | 12 | 13.79% |
United Kingdom | 7 | 8.05% |
Germany | 1 | 1.15% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Raffaele Petrone
- Personal Network